We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
-16.25%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.63B
AUM Growth
-$758M
Cap. Flow
-$358M
Cap. Flow %
-22.01%
Top 10 Hldgs %
47.54%
Holding
408
New
22
Increased
69
Reduced
110
Closed
53

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$21.2M
2
LLY icon
Eli Lilly
LLY
+$19.2M
3
MCD icon
McDonald's
MCD
+$9.1M
4
DHI icon
D.R. Horton
DHI
+$8.44M
5
LIN icon
Linde
LIN
+$8.43M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$53.8M
2
UPS icon
United Parcel Service
UPS
+$49.1M
3
PANW icon
Palo Alto Networks
PANW
+$48.1M
4
GS icon
Goldman Sachs
GS
+$45.4M
5
CVX icon
Chevron
CVX
+$41.4M

Sector Composition

Rank Sector Weight
1 Technology 23.86%
2 Industrials 17.87%
3 Healthcare 12.42%
4 Consumer Discretionary 9.18%
5 Consumer Staples 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$171M 10.5%
1,250,095
-211,288
-14% -$32M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.9T
$96.8M 5.95%
884,800
-48,740
-5% -$5.76M
MSFT icon
3
Microsoft
MSFT
$2.84T
$93.2M 5.73%
362,922
-23,116
-6% -$6.27M
AMZN icon
4
Amazon
AMZN
$2.5T
$88.2M 5.42%
830,256
-49,044
-6% -$6.14M
COST icon
5
Costco
COST
$415B
$86.1M 5.29%
179,627
-9,899
-5% -$5.02M
CVX icon
6
Chevron
CVX
$388B
$58.1M 3.57%
401,164
-250,306
-38% -$41.4M
TMO icon
7
Thermo Fisher Scientific
TMO
$211B
$48.5M 2.98%
89,329
-1,139
-1% -$627K
DE icon
8
Deere & Co
DE
$170B
$46.7M 2.87%
155,880
-7,213
-4% -$2.66M
LNG icon
9
Cheniere Energy
LNG
$56.5B
$43.8M 2.69%
329,279
-62,182
-16% -$8.47M
SYK icon
10
Stryker
SYK
$127B
$41.5M 2.55%
208,799
-85
-0% -$20K
UNP icon
11
Union Pacific
UNP
$183B
$40M 2.46%
187,692
-415
-0.2% -$94.4K
PG icon
12
Procter & Gamble
PG
$343B
$39.6M 2.43%
275,418
+4,314
+2% +$648K
CAT icon
13
Caterpillar
CAT
$409B
$39.5M 2.43%
221,168
-819
-0.4% -$173K
CB icon
14
Chubb
CB
$140B
$39.3M 2.41%
199,930
+1,453
+0.7% +$299K
ABT icon
15
Abbott
ABT
$180B
$37.6M 2.31%
345,860
-9,566
-3% -$1.09M
J icon
16
Jacobs Solutions
J
$15.9B
$37.1M 2.28%
352,411
-6,050
-2% -$677K
LMT icon
17
Lockheed Martin
LMT
$134B
$35.9M 2.2%
83,424
-1,740
-2% -$764K
ADP icon
18
Automatic Data Processing
ADP
$100B
$33.4M 2.05%
158,815
-1,088
-0.7% -$238K
HON icon
19
Honeywell
HON
$77.1B
$32.7M 2.01%
199,327
-383
-0.2% -$68.8K
ADI icon
20
Analog Devices
ADI
$181B
$32.1M 1.97%
219,550
+134,544
+158% +$21.2M
NVDA icon
21
NVIDIA
NVDA
$5.01T
$26.9M 1.65%
1,771,330
-34,930
-2% -$659K
LLY icon
22
Eli Lilly
LLY
$1.07T
$20.7M 1.27%
+63,984
New +$19.2M
IVV icon
23
iShares Core S&P 500 ETF
IVV
$876B
$20.2M 1.24%
53,329
-4,871
-8% -$2M
EW icon
24
Edwards Lifesciences
EW
$47.6B
$19.4M 1.19%
203,647
+995
+0.5% +$103K
ETN icon
25
Eaton
ETN
$157B
$18.1M 1.11%
143,791
+649
+0.5% +$90.8K
1
2 3 4 5

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q2 2022 Portfolio in Review

As of Q2 2022, R.H. Bluestein & Co held 408 positions worth $1.63B, down 32% from $2.39B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

R.H. Bluestein & Co withdrew a net $358M in Q2 2022, closing 53 positions and reducing 110 holdings. Its most notable exit was Goldman Sachs, an estimated $45.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, R.H. Bluestein & Co opened a new position in Eli Lilly worth $20.7M.

  • R.H. Bluestein & Co's largest Q2 2022 buy was Eli Lilly: 63,984 shares worth $20.7M.
  • R.H. Bluestein & Co added most to Analog Devices in Q2 2022, an estimated $21.2M increase.
  • R.H. Bluestein & Co's biggest Q2 2022 reduction was Home Depot, cutting an estimated $53.8M.
  • R.H. Bluestein & Co fully exited Goldman Sachs in Q2 2022, selling an estimated $45.4M.
  • R.H. Bluestein & Co's ten largest holdings make up 48% of its $1.63B portfolio in Q2 2022.
  • R.H. Bluestein & Co opened 22 new positions and closed 53 in Q2 2022.
  • R.H. Bluestein & Co's portfolio value fell 32% quarter-over-quarter to $1.63B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2022, filed 11 Aug 2022.